Greenberg PL - Search Results

1

TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups.

Haase D, Stevenson KE, Neuberg D, Maciejewski JP, Nazha A, Sekeres MA, Ebert BL, Garcia-Manero G, Haferlach C, Haferlach T, Kern W, Ogawa S, Nagata Y, Yoshida K, Graubert TA, Walter MJ, List AF, Komrokji RS, Padron E, Sallman D, Papaemmanuil E, Campbell PJ, Savona MR, Seegmiller A, Adès L, Fenaux P, Shih LY, Bowen D, Groves MJ, Tauro S, Fontenay M, Kosmider O, Bar-Natan M, Steensma D, Stone R, Heuser M, Thol F, Cazzola M, Malcovati L, Karsan A, Ganster C, Hellström-Lindberg E, Boultwood J, Pellagatti A, Santini V, Quek L, Vyas P, Tüchler H, Greenberg PL, Bejar R; International Working Group for MDS Molecular Prognostic Committee. Haase D, et al. Among authors: greenberg pl. Leukemia. 2019 Jul;33(7):1747-1758. doi: 10.1038/s41375-018-0351-2. Epub 2019 Jan 11. Leukemia. 2019. PMID: 30635634 Free PMC article.

2

Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes.

Nagler A, Ginzton N, Negrin R, Bang D, Donlon T, Greenberg P. Nagler A, et al. Leukemia. 1990 Mar;4(3):193-202. Leukemia. 1990. PMID: 1690318

3

Treatment of myelodysplastic syndromes.

Greenberg PL. Greenberg PL. Blood Rev. 1991 Mar;5(1):42-50. doi: 10.1016/0268-960x(91)90007-y. Blood Rev. 1991. PMID: 1709576 Review.

4

Biologic nature of the myelodysplastic syndromes.

Greenberg PL. Greenberg PL. Acta Haematol. 1987;78 Suppl 1:94-9. doi: 10.1159/000205911. Acta Haematol. 1987. PMID: 2829490 Review.

5

Mutations in the ras proto-oncogenes in patients with myelodysplastic syndromes.

Neubauer A, Greenberg P, Negrin R, Ginzton N, Liu E. Neubauer A, et al. Leukemia. 1994 Apr;8(4):638-41. Leukemia. 1994. PMID: 7512175

6

Effects of granulocyte colony-stimulating factor therapy on in vitro hemopoiesis in myelodysplastic syndromes.

Nagler A, MacKichan ML, Negrin RS, Donlon T, Greenberg PL. Nagler A, et al. Among authors: greenberg pl. Leukemia. 1995 Jan;9(1):30-9. Leukemia. 1995. PMID: 7531261

7

International scoring system for evaluating prognosis in myelodysplastic syndromes.

Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J. Greenberg P, et al. Blood. 1997 Mar 15;89(6):2079-88. Blood. 1997. PMID: 9058730 Free article.

8

Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model.

Hellström-Lindberg E, Negrin R, Stein R, Krantz S, Lindberg G, Vardiman J, Ost A, Greenberg P. Hellström-Lindberg E, et al. Br J Haematol. 1997 Nov;99(2):344-51. doi: 10.1046/j.1365-2141.1997.4013211.x. Br J Haematol. 1997. PMID: 9375752 Free article. Clinical Trial.

9

Prognostic factors and scoring systems in myelodysplastic syndromes.

Sanz GF, Sanz MA, Greenberg PL. Sanz GF, et al. Among authors: greenberg pl. Haematologica. 1998 Apr;83(4):358-68. Haematologica. 1998. PMID: 9592987 Review.

10

Bcl-2 expression by myeloid precursors in myelodysplastic syndromes: relation to disease progression.

Davis RE, Greenberg PL. Davis RE, et al. Among authors: greenberg pl. Leuk Res. 1998 Sep;22(9):767-77. doi: 10.1016/s0145-2126(98)00051-4. Leuk Res. 1998. PMID: 9716007 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page